Your browser doesn't support javascript.
loading
Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?
Verweij, Paul E; Arendrup, Maiken C; Alastruey-Izquierdo, Ana; Gold, Jeremy A W; Lockhart, Shawn R; Chiller, Tom; White, P Lewis.
  • Verweij PE; Department of Medical Microbiology and Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, the Netherlands; Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bil
  • Arendrup MC; Unit for Mycology, Statens Serum Insitut, Copenhagen, Denmark; Department of Medical Microbiology, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
  • Alastruey-Izquierdo A; Mycology Reference Laboratory, Instituto de Salud Carlos III, Madrid, Spain.
  • Gold JAW; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.
  • Lockhart SR; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.
  • Chiller T; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.
  • White PL; Public Health Wales Mycology Reference Laboratory, Cardiff, United Kingdom.
Drug Resist Updat ; 65: 100885, 2022 12.
Article en En | MEDLINE | ID: mdl-36283187
ABSTRACT
Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fungicidas Industriales / Antifúngicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fungicidas Industriales / Antifúngicos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article